# Lexicon Pharmaceuticals (LXRX) — Analyst Forecast

LXRX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lxrx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 4 | 2 | 0 | 6 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 28, 2026 | Cantor Fitzgerald | Initiated Coverage | Overweight | $8.00 |
| May 11, 2026 | Citigroup | Maintained | Buy | $3.10 |
| Mar 23, 2026 | HC Wainwright & Co. | Maintained | Buy | $6.00 |
| Mar 10, 2026 | Citigroup | Maintained | Buy | $2.30 |
| Mar 5, 2026 | HC Wainwright & Co. | Maintained | Buy | $6.00 |
| Sep 2, 2025 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| Aug 7, 2025 | Citigroup | Maintained | Buy | $1.90 |
| Jun 24, 2025 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| Mar 28, 2025 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| Mar 7, 2025 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| Mar 7, 2025 | Needham | Maintained | Hold | — |
| Mar 7, 2025 | Piper Sandler | Maintained | Overweight | $6.00 |
| Mar 4, 2025 | Leerink Partners | Downgraded | Outperform → Market Perform | $1.00 |
| Mar 3, 2025 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| Mar 3, 2025 | Needham | Maintained | Hold | — |
| Jan 29, 2025 | Needham | Maintained | Hold | — |
| Jan 29, 2025 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| Dec 23, 2024 | Needham | Maintained | Hold | — |
| Nov 25, 2024 | Needham | Maintained | Hold | — |
| Nov 22, 2024 | Needham | Maintained | Hold | — |

## Frequently Asked Questions

### Is LXRX a buy, sell, or hold?

Analysts covering Lexicon Pharmaceuticals currently average a Buy rating: 4 buy, 2 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on LXRX?

On Sep 28, 2026, Cantor Fitzgerald initiated coverage of Lexicon Pharmaceuticals at Overweight with a price target of $8.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).